Bioenergy Life Science

Ingredients for Healthier Living™

Our Story

We develop new all-natural, pure and scientifically-based ingredients that help people feel better, perform better and look better.

We’re best known for the development of the multi-functional molecule D-Ribose. Bioenergy Ribose® is the only patented and FDA GRAS-certified ribose on the market. We use this core technology and our more than 30 years of experience to develop clinically-proven health-enhancing ingredients that help people of all ages feel, perform and look better from the inside out.

We sell in bulk to businesses who manufacture or formulate functional foods and beverages, dietary supplements, sports nutrition products and cosmetics.

Our company’s foundation is based on research by pediatric, cardiothoracic surgeon, John E. Foker, MD, Ph.D.

Dr. Foker uncovered the temporal relationship between the amount of energy in the heart and its diastolic functions such as the ability to relax before contraction. Bioenergy Ribose drives the synthesis and replenishment of critical energy compound (i.e. ATP). This supports overall cardiovascular health and overall vitality.

Dr. Foker realized that an invasive cardiac procedure for a congenital defect often led to additional issues in his young patients. In an effort to improve outcomes for these children, he conducted substantial pre-clinical research and discovered that D-Ribose helped alleviate the potential for further damage from the cardiac procedure. He was granted a patent in 1988 for this life-changing discovery.

Research at the University of Minnesota led to additional patents and the formation of Bioenergy Inc.

Timeline

1950s

Initial uses of D-Ribose discovered

1990

Bioenergy, Inc. established to develop Bioenergy Ribose

1996

Bioenergy Ribose production started

1998

Family of patents concerning the known uses and benefits of D-Ribose were granted

2001

Launch of Bioenergy Ribose in dietary supplements

2005

Medical foods formulated with Corvalen are launched

2007

Additional patents granted for use of Bioenergy Ribose

2010

Additional patents granted for use of Bioenergy Ribose

2013

Bioenergy Ribose use expands to cosmetics market

2016

Additional patents granted for use of Bioenergy Ribose

1987

Research by University of Minnesota pediatric cardiovascular surgeon Dr. John Foker confirms D-Ribose health benefits

1991

Continued Bioenergy Ribose research and clinical studies

1997

Corvalen brand created

2000

Bioenergy Ribose receives GRAS affirmation and FDA “No Questions Letter”

2003

First sports nutrition products with Bioenergy Ribose hit the market

2007

Bioenergy Ribose use expands to functional beverages

2008

Team Ribose formed

2012

First functional food with Bioenergy Ribose launched

2014

Bioenergy Ribose use expands to animal nutrition market

2018

Launch of RiaGev, backed by clinical studies and patent

1950s

Initial uses of D-Ribose discovered

1987

Research by University of Minnesota pediatric cardiovascular surgeon Dr. John Foker confirms D-Ribose health benefits

1990

Bioenergy, Inc. established to develop Bioenergy Ribose

1991

Continued Bioenergy Ribose research and clinical studies

1996

Bioenergy Ribose production started

1997

Corvalen brand created

1998

Family of patents concerning the known uses and benefits of D-Ribose were granted

2000

Bioenergy Ribose receives GRAS affirmation and FDA “No Questions Letter”

2001

Launch of Bioenergy Ribose in dietary supplements

2003

First sports nutrition products with Bioenergy Ribose hit the market

2005

Medical foods formulated with Corvalen are launched

2007

Bioenergy Ribose use expands to functional beverages

2007

Additional patents granted for use of Bioenergy Ribose

2008

Team Ribose formed

2010

Additional patents granted for use of Bioenergy Ribose

2012

First functional food with Bioenergy Ribose launched

2013

Bioenergy Ribose use expands to cosmetics market

2014

Bioenergy Ribose use expands to animal nutrition market

2016

Additional patents granted for use of Bioenergy Ribose

2018

Launch of RiaGev, backed by clinical studies and patent